These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 15274325)
1. mRNA expression of the angiogenesis markers VEGF and CD105 (endoglin) in human breast cancer. Gómez-Esquer F; Agudo D; Martínez-Arribas F; Nuñez-Villar MJ; Schneider J Anticancer Res; 2004; 24(3a):1581-5. PubMed ID: 15274325 [TBL] [Abstract][Full Text] [Related]
2. [Clinicopathologic significance of CD105 mRNA expression in human breast carcinoma]. Pang D; Liu F; Xue YW; Zhang QF Zhonghua Zhong Liu Za Zhi; 2005 Jan; 27(1):38-40. PubMed ID: 15771797 [TBL] [Abstract][Full Text] [Related]
4. Eukaryotic initiation factor 4E (eIF4E) and angiogenesis: prognostic markers for breast cancer. Zhou S; Wang GP; Liu C; Zhou M BMC Cancer; 2006 Sep; 6():231. PubMed ID: 17010208 [TBL] [Abstract][Full Text] [Related]
5. Bcl-2 expression in breast cancer: a comparative study at the mRNA and protein level. Martínez-Arribas F; Alvarez T; Del Val G; Martín-Garabato E; Núñez-Villar MJ; Lucas R; Sánchez J; Tejerina A; Schneider J Anticancer Res; 2007; 27(1A):219-22. PubMed ID: 17352236 [TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical evaluation of the microvascular density through the expression of TGF-beta (CD 105/endoglin) and CD 34 receptors and expression of the vascular endothelial growth factor (VEGF) in oligodendrogliomas. Netto GC; Bleil CB; Hilbig A; Coutinho LM Neuropathology; 2008 Feb; 28(1):17-23. PubMed ID: 18181830 [TBL] [Abstract][Full Text] [Related]
7. [Relevance of Endoglin (CD105) VEGF and p53 with invasion metastasis and prognosis of laryngeal carcinoma]. Li Q; Zhang B; Peng P Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2007 Dec; 21(24):1114-7. PubMed ID: 18330257 [TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of microvessel density determined by an anti-CD105/endoglin monoclonal antibody in astrocytic tumors: comparison with an anti-CD31 monoclonal antibody. Yao Y; Kubota T; Takeuchi H; Sato K Neuropathology; 2005 Sep; 25(3):201-6. PubMed ID: 16193836 [TBL] [Abstract][Full Text] [Related]
9. Endoglin (CD105) and vascular endothelial growth factor as prognostic markers in colorectal cancer. Saad RS; Liu YL; Nathan G; Celebrezze J; Medich D; Silverman JF Mod Pathol; 2004 Feb; 17(2):197-203. PubMed ID: 14657950 [TBL] [Abstract][Full Text] [Related]
10. Relationship between expression of CD105 and growth factors in malignant tumors of gastrointestinal tract and its significance. Yu JX; Zhang XT; Liao YQ; Zhang QY; Chen H; Lin M; Kumar S World J Gastroenterol; 2003 Dec; 9(12):2866-9. PubMed ID: 14669355 [TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor-beta binding receptor endoglin (CD105) expression in esophageal cancer and in adjacent nontumorous esophagus as prognostic predictor of recurrence. Bellone G; Solerio D; Chiusa L; Brondino G; Carbone A; Prati A; Scirelli T; Camandona M; Palestro G; Dei Poli M Ann Surg Oncol; 2007 Nov; 14(11):3232-42. PubMed ID: 17682823 [TBL] [Abstract][Full Text] [Related]
13. Proliferation measurement in breast cancer by two different methods. Martínez-Arribas F; Martín-Garabato E; Lafuente P; Tejerina A; Lucas R; Sánchez J; Schneider J Anticancer Res; 2006; 26(1A):199-202. PubMed ID: 16475699 [TBL] [Abstract][Full Text] [Related]
14. CD105 promotes hepatocarcinoma cell invasion and metastasis through VEGF. Li Y; Zhai Z; Liu D; Zhong X; Meng X; Yang Q; Liu J; Li H Tumour Biol; 2015 Feb; 36(2):737-45. PubMed ID: 25286761 [TBL] [Abstract][Full Text] [Related]
15. Upregulation of endoglin (CD105) expression during childhood brain tumor-related angiogenesis. Anti-angiogenic therapy. Bodey B; Bodey B; Siegel SE; Kaiser HE Anticancer Res; 1998; 18(3A):1485-500. PubMed ID: 9673360 [TBL] [Abstract][Full Text] [Related]
16. Endoglin (CD105) expression in angiogenesis of primary hepatocellular carcinomas: analysis using tissue microarrays and comparisons with CD34 and VEGF. Yao Y; Pan Y; Chen J; Sun X; Qiu Y; Ding Y Ann Clin Lab Sci; 2007; 37(1):39-48. PubMed ID: 17311868 [TBL] [Abstract][Full Text] [Related]
17. Endoglin (CD105) and vascular endothelial growth factor as prognostic markers in esophageal adenocarcinoma. Saad RS; El-Gohary Y; Memari E; Liu YL; Silverman JF Hum Pathol; 2005 Sep; 36(9):955-61. PubMed ID: 16153457 [TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of angiogenesis evaluated by CD105 expression compared to CD31 in 905 breast carcinomas: correlation with long-term patient outcome. Dales JP; Garcia S; Andrac L; Carpentier S; Ramuz O; Lavaut MN; Allasia C; Bonnier P; Charpin C Int J Oncol; 2004 May; 24(5):1197-204. PubMed ID: 15067342 [TBL] [Abstract][Full Text] [Related]
19. Endoglin is a better marker than CD31 in evaluation of angiogenesis in glioblastoma. Behrem S; Zarkovic K; Eskinja N; Jonjic N Croat Med J; 2005 Jun; 46(3):417-22. PubMed ID: 15861521 [TBL] [Abstract][Full Text] [Related]
20. Endoglin (CD105) and vascular endothelial growth factor as prognostic markers in prostatic adenocarcinoma. El-Gohary YM; Silverman JF; Olson PR; Liu YL; Cohen JK; Miller R; Saad RS Am J Clin Pathol; 2007 Apr; 127(4):572-9. PubMed ID: 17369132 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]